tirzepatide mechanism of action gip for Weight Loss (Fat Loss) Tirzepatide, a dual GIP/GLP-1 receptor

Although recent reviews have described the role of GLP-1 RAs on cardiovascular risk in general, there is a lack of evidence synthesis on local actions of GLP-1 RAs in coronary arteries and the link of these mechanisms to coronary events ((Figure 1)

We think that peptide therapy works best when it is part of a whole approach

What is GHK-Cu peptide used for

Patients with significant kidney or liver disease, certain gastrointestinal conditions, or specific medication interactions also need careful assessment

However, if you are concerned or are experiencing side effects that are difficult to manage, you should speak to your doctor